Global Genitourinary Drugs Market

1. Summary

The Global Genitourinary Drugs Market was valued at $30.1 bn. in 2025. During the forecast period 2025-2030, it is expected to grow at 1.7% CAGR, to an estimated market size of $32.7 bn. in 2030. A detailed breakdown by segment and geography is provided in the downloadable datasheet.

2. Market Definition

The genitourinary drugs market encompasses pharmaceutical treatments and therapies designed to manage conditions affecting the urinary tract and the male and female reproductive systems. The scope includes medications for urological cancers (prostate, bladder, renal, ovarian, cervical), functional disorders (erectile dysfunction, urinary incontinence, benign prostatic hyperplasia), and infections such as urinary tract infections (UTIs) and sexually transmitted diseases.

3. Trends & Demand Drivers

Several key trends are expected to significantly impact the Genitourinary Drugs Market in the period 2025-30:

• Increasing adoption of antibody-drug conjugates (ADCs) and targeted therapies is improving efficacy in treating drug-resistant prostate and bladder cancers.
• The aging global population is driving a significant rise in the prevalence of age-related conditions such as benign prostatic hyperplasia and urinary incontinence.
• Development of first-in-class antibiotics, such as gepotidacin, is essential to address the growing threat of multidrug-resistant urinary tract infections.
• Integration of AI-driven diagnostics and molecular biomarkers is enabling earlier detection and more personalized treatment pathways for urological oncology.
• Expansion of telemedicine and digital health platforms is increasing patient access to prescriptions for sensitive conditions like erectile dysfunction.
• A strategic shift toward precision medicine and long-acting injectable formulations is helping manufacturers offset the impact of patent cliffs for legacy blockbusters.
• Rising healthcare infrastructure investment in emerging economies is broadening access to specialized genitourinary care and hormonal therapies.

4. Market Breakdown

The downloadable datasheet breaks market sizes and growth rates (CAGRs) down into the following geographies and segments: